Lavrov, Kerry discuss militants’ withdrawal from Aleppo — Russian foreign ministryRussian Politics & Diplomacy December 08, 21:00
Lavrov: Combat actions in Aleppo suspended to take civilians out of cityRussian Politics & Diplomacy December 08, 20:56
Bach says WADA to play part in deciding on 2021 IBU World Championship in RussiaSport December 08, 20:44
Gazprom signs contract for construction of Turkish Stream’s first line with AllseasBusiness & Economy December 08, 20:03
Russian Energy Ministry confirms non-OPEC countries meeting date as December 10 in ViennaBusiness & Economy December 08, 19:59
IOC chief Bach urges personal approach system to fight doping abuse in sportsSport December 08, 19:51
Deripaska’s suit against Montenegro falls under investment protection pact — CEACBusiness & Economy December 08, 19:35
Putin says Moscow will never accept West’s position on death of Russian medics in SyriaRussian Politics & Diplomacy December 08, 18:44
Court postpones trial of FAS fine against Google until January 17Business & Economy December 08, 18:42
DALIAN, China, Sept. 23, 2016 /PRNewswire/. On 21st Sept., the 2016 "Healthy China" Forum, hosted by the committee of Global Innovation Forum and sponsored by ZHEN-AO, Shuangdi, Inc. and Gene Tech Biotechnology Co. Ltd., was held in Dalian.
Experts at home and abroad attending the forum and exchanged their ideas and views on the future development of biotechnological innovation and advanced achievements based on current accomplishment of technological innovation of biotechnology and nucleotide. Rolf M. Zinkernagel, the Nobel laureate of Physiology or Medicine, Professor of University of Zurich, also attended the forum and introduced the cutting-edge researches on the safety and nutritional function of nucleotide as well as its future application in immunity and health field.
"Healthy China" is becoming a national strategy and provides a great opportunity for Precision Medicine industry. While enterprises, as a saying goes, "to forge iron, one must be strong", should never stop innovating so as to win the market, according to Chen Yuqi, the vice chairman of China Nutrition and Health Food Association, vice president of China Health Care Association and Chairman & CEO of ZHEN-AO.
ZHEN-AO, based in ZHEN-AO Bio Valley and located in Dalian Advanced Equipment Manufacturing Zone with an area of 38,000 square meters and a total investment over 2.2 billion yuan, is the first enterprise that introduced nucleotide to Chinese families. Bio-manufacturing, bio-pharmaceuticals, biological products, biological agriculture and biological environmental protection constitute the main pillar industries of ZHEN-AO.
Image Attachments Links:
CONTACT: Ms. Liu, Tel: 86 10 63074558